ArticleESMO real world data and digital oncology2025
Perspectives, willingness, and current use of mobile health (mHealth) by patients with cancer for remote monitoring during cancer treatment: a Dutch national cross-sectional survey.
Article in ESMO real world data and digital oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Digital solutions, real-world challenges: lessons from mHealth trials in oncology.Frontiers in digital health · 2025Trial
- Mobile Health Technology Ownership and Use Among Cancer Survivors in a Health System.Cancer reports (Hoboken, N.J.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The use of mobile health (mHealth) tools for remote monitoring of patients during oncological treatment appears to be a feasible option to complement traditional outcomes by objectively assessing patient fitness, collecting patient-reported outcomes, or assisting with clinical decision making. However, scarce research has been done regarding the current state of these tools. This study aimed to assess the willingness and current use of mHealth among patients with cancer and cancer survivors. Patients and methods: Cross-sectional data were collected via a nationwide survey in the Netherlands through the Dutch Federation of Cancer Patients' platform in April 2023. Descriptive statistics and comparisons were made using chi-square tests and logistic regression. Results: Of the 4196 respondents, 3346 (80%) used a smartphone, 2367 (56%) a tablet, and 1285 (31%) a wearable (i.e. smartwatch). A total of 2927 (70%) respondents were willing to use an application (app) and 2481 (60%) a wearable for health-related purposes. Younger age and higher education level were significantly associated with a higher willingness to use apps ( Conclusion: There is a rich window of opportunity for research in remote monitoring of patients with cancer using mHealth tools, as most patients either already use them, or are willing to, for health-related purposes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.